The FDA approvals page was updated on April 10th to include 5 additional approvals, bringing the total for March to 19 (up from the 14 reported earlier). The number of tentative approvals did not change.
The good news is that April is starting out to have some promising numbers. Through April 9th, the database reports 12 approvals. This is especially encouraging since the Easter holiday (also spring break) fell over a period of time where many of the OGD review staff typically take vacation.
So maybe April is the month that we begin to see improvement in approvals coming out of OGD. We will report back at the end of the month.
